Nomura Micro Science Co., Ltd.

Nomura Micro Science Co., Ltd.

16.70
EUR
-0.50
(-2.91%)
Nov 13Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
419.24
340.74
499.88
462.69
597.37
689.53
574.8
825.58
866.51
1,340.11
1,953.85
2,557.88
1,478.41
- -
Basic EPS, GAAP
-11.33
-27.68
4.25
19.43
27.77
28.26
34.77
71.2
89.4
156.9
213.47
270.75
100.36
- -
Free Cash Flow per Basic Share
-10.7
4.44
-23.54
32.11
-62.95
95.23
-8.84
157.71
20.95
98.75
-508.9
-593.77
78.15
- -
Dividend per Share
3.09
2
- -
0.75
3.67
4.98
7.46
8.24
23.67
26.16
42.33
67.17
79.6
- -
Book Value per Share
218.02
202.56
195.68
216.78
241.37
261.8
280.94
358.48
432.57
574.93
771.02
977.57
1,040.85
- -
Tangible Book Value per Share
212.12
201.67
195.09
216.34
241
261.38
280.55
358.11
428.19
571.35
768.22
974.42
1,038.77
- -
Basic Weighted Avg Shares
36
36
36
36
36
36
37
37
37
37
37
38
38
38
Sales/Revenue/Turnover
14,985
12,111
17,768
16,455
21,603
25,132
21,049
30,361
31,901
49,596
73,021
96,360
56,246
- -
Operating Margin (%)
-4.58
-4.54
1.78
4.68
5.74
4.83
8.77
13.09
13.9
13.21
14.58
15.95
11.85
- -
Depreciation Expense
345
417
298
225
182
190
179
125
172
191
307
1,653
1,693
- -
Net Income, GAAP
-405
-984
151
691
1,004
1,030
1,273
2,618
3,292
5,807
7,978
10,200
3,818
- -
Effective Tax Rate (%)
- -
- -
16.68
6.92
11.15
24.86
28.83
27.46
28.11
22.06
26.32
23.88
32.37
- -
Profit Margin (%)
-2.7
-8.12
0.85
4.2
4.65
4.1
6.05
8.62
10.32
11.71
10.93
10.58
6.79
- -
Working Capital
3,649
3,597
3,493
4,404
4,831
6,469
8,061
10,252
12,641
17,136
24,224
30,096
31,774
- -
LT Debt
35
16
3
2
45
38
28
16
25
16
8
498
1,616
- -
Total Equity
7,754
7,209
6,963
7,757
8,786
9,548
10,315
13,190
15,932
21,401
28,924
37,014
39,853
- -
Return on Invested Capital (%)
- -
- -
2.4
6.27
8.16
6.32
9.53
18.8
17.59
22.55
19.93
15.93
4.74
- -
Return on Capital (%)
- -
- -
1.67
6.38
7.9
7.55
9.61
17.99
19.24
26.91
22.08
16.46
5.89
- -
Return on Common Equity (%)
-5.1
-13.16
2.14
9.4
12.15
11.24
12.82
22.28
22.6
31.11
31.71
30.94
9.93
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
48,435
51,373
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1,701
1,616
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
38
38
38
Market Capitalization
- -
- -
- -

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
94,523
99,987
- -
Cash, Cash Equivalents & STI
16,434
10,425
- -
Accounts Receivable, Net
69,727
4,419
- -
Inventories
4,480
5,182
- -
Total Current Liabilities
64,867
68,214
- -
Payables & Accruals
- -
- -
- -
ST Debt
48,435
51,373
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.51%
25.18%
7.67%
Free Cash Flow
-321.93%
-85.8%
-113.29%
Net Income, GAAP
63.9%
20.96%
-62.57%
Sales/Revenue/Turnover
16.63%
19.62%
-41.63%
Total Cash Common Dividend
2,342.12%
68.36%
19.68%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
96,360
2026
- -
- -
- -
- -
56,246
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
270.75
2026
- -
- -
- -
- -
100.36
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
67.17
2026
- -
- -
- -
- -
79.6
2027
- -
- -
- -
- -
- -

Company Description

CEO
Makoto Uchida
Full Time Employees
623
Sector
Producer manufacturing
Industry
Industrial machinery
Address
2-9-8, Okata Atsugi KN Japan 243-0021
IPO Date
Oct 5, 2007
Business
Nomura Micro Science Co., Ltd. (6254.T) designs, manufactures, installs, sells, and maintains advanced water treatment systems, including ultrapure water production systems for the electronics and high-precision device industries; pharmaceutical water production systems, pure steam generators for sterilization, package-type purified water systems, and membrane-based water for injection (WFI) production systems; wastewater treatment and water reclamation systems; and related functional products such as pretreatment membrane systems (FINESEP NFS Series), heat regenerative membrane filtration equipment (HEATMASTER HM Series), electrodeionization (EDI) systems, high-efficiency reverse osmosis systems (HERO), high-efficiency vacuum degasifiers (HE-VDG), membrane degasifiers, ozone water production systems (NOMUREXON O3), hydrogen water production systems (NOMUREXON H2), anti-static equipment (Super Bubbler WAC), return contamination monitors (RC Monitor), H2O2 monitors for ultrapure water (NOXiEMON), Nuclepore membranes, filter cartridges (NOMULITE), piping and environmental materials, and on-site pure water supply services. Founded in 1969 and headquartered at 2-9-10 Okata, Atsugi-shi, Kanagawa-ken, Japan, the company operates primarily in Japan, with subsidiaries and activities spanning South Korea (Nomura Micro Science Korea Co., Ltd.), the United States (Nomura Micro Science USA Ltd., Co.), Taiwan (Nomura Micro Science Engineering Co., Ltd.), China (Shanghai Nomura Engineering Co., Ltd.), Singapore (Nomura Micro Science Singapore Pte. Ltd.), and other Asian markets, serving electronics, pharmaceuticals, biotechnology, food, plants, environmental energy, and analysis industries. Recent developments include Shanghai Nomura Engineering Co., Ltd. absorbing Nomura Shanghai Engineering Technology Co., Ltd. as the surviving entity in 2025; establishment of Nomura Micro Science Singapore Pte. Ltd. in 2024 to bolster Southeast Asia sales; acquisition of full equity in Hydrofoil (Shanghai) Engineering Co., Ltd. (renamed Nomura Shanghai Engineering Technology Co., Ltd.) in 2023; record FY2025 financial performance driven by major water treatment projects in the United States and South Korea, alongside new orders in India (TATA project); and strategic initiatives such as global sales expansion, engineering process reforms including skid mounting and piping prefabrication, accelerated R&D under the SMART UP3 program for next-generation ultrapure water and environmental systems, and growing sales of WFI manufacturing systems with endotoxin monitoring development.